Zacks: Analysts Set $111.67 Target Price for China Biologic Products Holdings, Inc.

Zacks: Analysts Set $111.67 Target Price for China Biologic Products Holdings, Inc.


China Biologic Products Holdings, Inc. has earned a consensus broker rating score of 1.00 from the three analysts that provide coverage for the company, Zacks Investment Research reports. Three analysts have rated the stock with a strong buy rating.



from Biotech News